ConductScience.org, home

Paper34840249

Liquid biopsies in pediatric oncology: opportunities and obstacles.

Sundby RT and 2 others. Curr Opin Pediatr, 2022. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Liquid biopsies in pediatric oncology: opportunities and obstacles. Papers, record 34840249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34840249

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Liquid biopsies in pediatric oncology: opportunities and obstacles.
PubMed
Journal
Curr Opin Pediatr
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.33
iCite
Revised in PubMed
2025-05-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sundby RTR Taylor
2Pan AAlex
3Shern JFJack F

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Medical OncologyMajor topic
Adult
Biopsy
Child
Humans
Liquid Biopsy
Neoplasm, Residual

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Z99 CA999999Intramural NIH HHSUnited StatesZ99CA999999PubMedNIH RePORTER
ZIA BC011722Intramural NIH HHSUnited StatesZIABC011722PubMed and NIHNIH RePORTER

Download CSV of grants

References112

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123770567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013https://conductscience.org/library/papers/23770567PubMed
228420725Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine.Clin Cancer Res2017https://conductscience.org/library/papers/28420725PubMed
333283168Digital PCR for BCR-ABL1 Quantification in CML: Current Applications in Clinical Practice.Hemasphere2020https://conductscience.org/library/papers/33283168PubMed
422561516Detectable clonal mosaicism from birth to old age and its relationship to cancer.Nat Genet2012https://conductscience.org/library/papers/22561516PubMed
532633890Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience.Cancer Med2020https://conductscience.org/library/papers/32633890PubMed
627440268Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma.Clin Cancer Res2016https://conductscience.org/library/papers/27440268PubMed
79915961Rapid clearance of fetal DNA from maternal plasma.Am J Hum Genet1999https://conductscience.org/library/papers/9915961PubMed
824710217The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes.Nat Commun2014https://conductscience.org/library/papers/24710217PubMed
931088252Opportunities and challenges of circulating biomarkers in neuroblastoma.Open Biol2019https://conductscience.org/library/papers/31088252PubMed
1028428148Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer.J Thorac Oncol2017https://conductscience.org/library/papers/28428148PubMed
1134050156Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.Nat Commun2021https://conductscience.org/library/papers/34050156PubMed
1231386611Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531.J Clin Oncol2019https://conductscience.org/library/papers/31386611PubMed
1328899864Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.Cancer Discov2017https://conductscience.org/library/papers/28899864PubMed
1426554728Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma.Nat Commun2015https://conductscience.org/library/papers/26554728PubMed
1524853859Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification.Anal Bioanal Chem2014https://conductscience.org/library/papers/24853859PubMed
1623484797Analysis of circulating tumor DNA to monitor metastatic breast cancer.N Engl J Med2013https://conductscience.org/library/papers/23484797PubMed
1729156716Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma.Oncotarget2017https://conductscience.org/library/papers/29156716PubMed
1830614191Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies.Pediatr Blood Cancer2019https://conductscience.org/library/papers/30614191PubMed
1919332714Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.J Clin Oncol2009https://conductscience.org/library/papers/19332714PubMed
2030172241Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors.Transl Oncol2018https://conductscience.org/library/papers/30172241PubMed

See all 112 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42977305Integrating PET/CT and correlative biomarkers for prospective evaluation of extramedullary disease in relapsed/refractory B-ALL: implications for CAR T-cell therapy.J Immunother Cancer2026https://conductscience.org/library/papers/42977305PubMed
42440508Liquid biopsy in pediatric acute lymphoblastic leukemia.Front Oncol2026https://conductscience.org/library/papers/42440508PubMed
41827811Pediatric Hepatoblastoma: From Developmental Molecular Mechanisms to Innovative Therapeutic Strategies.Cancers (Basel)2026https://conductscience.org/library/papers/41827811PubMed
39296266A First-in-Class High-Throughput Screen to Discover Modulators of the Alternative Lengthening of Telomeres (ALT) Pathway.ACS Pharmacol Transl Sci2024https://conductscience.org/library/papers/39296266PubMed
39097671A comprehensive overview of liquid biopsy applications in pediatric solid tumors.NPJ Precis Oncol2024https://conductscience.org/library/papers/39097671PubMed
39093127Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.Clin Cancer Res2024https://conductscience.org/library/papers/39093127PubMed
39062028Insights into Personalized Care Strategies for Wilms Tumor: A Narrative Literature Review.Biomedicines2024https://conductscience.org/library/papers/39062028PubMed
38710002Contemporary Approach to Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.Am Soc Clin Oncol Educ Book2024https://conductscience.org/library/papers/38710002PubMed
37904489Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.Clin Trials2024https://conductscience.org/library/papers/37904489PubMed
37398992Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.Clin Cancer Res2023https://conductscience.org/library/papers/37398992PubMed
37144257Circulating Cell-Free Tumor Deoxyribonucleic Acid Analysis as a Tool for the Diagnosis and Monitoring of Pediatric Solid Tumors.Turk Arch Pediatr2023https://conductscience.org/library/papers/37144257PubMed
36533693Cancer incidence and surveillance strategies in individuals with RASopathies.Am J Med Genet C Semin Med Genet2022https://conductscience.org/library/papers/36533693PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34840249

GET https://conductscience.org/api/papers/v1/34840249/references?page=2